AT182076T
Method of preventing nmda receptor complex-mediated neuronal damage.
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
62 members in 12 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 68896591 | United States of America | A |
Members62
| Document | Office | Kind | |
|---|---|---|---|
| WO9011761A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5419690A | Australia | A | |
| US5053419A | United States of America | A | |
| EP0465565A1 | European Patent Office (EPO) | A1 | |
| WO9203137A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP0465565A4 | European Patent Office (EPO) | A4 | |
| JPH04504260A | Japan | A | |
| WO9217168A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO9218112A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP0557290A4 | European Patent Office (EPO) | A4 | |
| US5234956A | United States of America | A | |
| EP0557290A1 | European Patent Office (EPO) | A1 | |
| JPH06500554A | Japan | A | |
| EP0581856A1 | European Patent Office (EPO) | A1 | |
| EP0581856A4 | European Patent Office (EPO) | A4 | |
| CA2143752A1 | Canada | A1 | |
| WO9405275A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4847693A | Australia | A | |
| WO9406428A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5348194A | Australia | A | |
| JPH06506690A | Japan | A | |
| US5334618A | United States of America | A | |
| EP0660707A1 | European Patent Office (EPO) | A1 | |
| EP0661973A1 | European Patent Office (EPO) | A1 | |
| US5455279A | United States of America | A | |
| JPH08501297A | Japan | A | |
| US5506231A | United States of America | A | |
| EP0465565B1 | European Patent Office (EPO) | B1 | |
| DE69027026D1 | Germany | D1 | |
| DE69027026T2 | Germany | T2 | |
| US5614560A | United States of America | A | |
| US5747545A | United States of America | A | |
| EP0660707A4 | European Patent Office (EPO) | A4 | |
| AU6351698A | Australia | A | |
| US5801203A | United States of America | A | |
| AU705888B2 | Australia | B2 | |
| EP0581856B1 | European Patent Office (EPO) | B1 | |
| AT182076TThis record | Austria | T | |
| DE69229598D1 | Germany | D1 | |
| ES2134804T3 | Spain | T3 | |
| DE69229598T2 | Germany | T2 | |
| EP0661973A4 | European Patent Office (EPO) | A4 | |
| US6071876A | United States of America | A | |
| EP0660707B1 | European Patent Office (EPO) | B1 | |
| AT202474T | Austria | T | |
| DE69330387D1 | Germany | D1 | |
| DK0660707T3 | Denmark | T3 | |
| ES2159528T3 | Spain | T3 | |
| PT660707E | Portugal | E | |
| GR3036657T3 | Greece | T3 | |
| DE69330387T2 | Germany | T2 | |
| JP3479532B2 | Japan | B2 | |
| JP2004043483A | Japan | A | |
| JP2006077034A | Japan | A | |
| JP2006117693A | Japan | A | |
| EP0661973B1 | European Patent Office (EPO) | B1 | |
| AT330606T | Austria | T | |
| DE69334035D1 | Germany | D1 | |
| DK0661973T3 | Denmark | T3 | |
| ES2264122T3 | Spain | T3 | |
| DE69334035T2 | Germany | T2 | |
| CA2143752C | Canada | C |
Numbers
- Application
- 92910911
Titles2
- German
- VERFAHREN ZUR VORBEUGUNG NMDA-REZEPTORKOMPLEX- VERMITTELTER NEURONALER SCHÄDEN
- English
- PROCEDURE FOR PREVENTING NMDA RECEPTOR COMPLEX-MEDIATED NEURONAL DAMAGE
Classification
- CPC, 17
- A61K9/7023
- A61K31/195
- A61K31/21
- A61K31/295
- A61P3/08
- A61P9/00
- A61P9/10
- A61P25/00
- A61P25/10
- A61P25/14
- A61P25/16
- A61P25/28
- A61P31/12
- A61P31/18
- A61P37/04
- A61P39/00
- A61P43/00
- IPC, 13
- A61K31 195
- A61K31 21
- A61K31 215
- A61K31 295
- A61K38 44
- A61K9 70
- A61P25 00
- A61P25 28
- A61P3 08
- A61P31 12
- A61P37 04
- A61P9 00
- A61P9 10